Cardiovascular Health

High-Dose Vitamin D Shows Anti-Inflammatory Effects in CHF

By Erik Goldman | Editor in Chief - Vol. 7, No. 2. Summer, 2006

Vitamin D deficiency correlates strongly with many heart disease risk factors. A new study from Germany shows that vitamin D supplementation produces beneficial anti-inflammatory changes in patients with congestive heart failure (CHF).

Obesity: WAT's Up With That?

By Erik Goldman | Editor in Chief - Vol. 7, No. 2. Summer, 2006

White Adipose Tissue (WAT), the raw material of love handles, secretes a wide range of signaling substances that can radically change metabolism. Dr. Jay Udani reviews the new science emerging on this topic, and explains why it becomes progressively more difficult for obese people to lose weight, even when they try very hard.

Melatonin: Circadian Cycle Regulator Has Role in Treatment of Cancer, Hypertension

By Erik L. Goldman | Editor in Chief - Vol. 7, No. 3. Fall, 2006

Most people think of melatonin as a sleep aid and jet lag remedy, owing to its ability to regulate circadian rhythms. But this compound has many other benefits, including regulation of blood pressure and slowing the growth of several types of cancer.

Vitamin E Supplements Raise Blood Pressure in Hypertensive People with Type 2 Diabetes

By Erik L. Goldman | Editor in Chief - Vol. 7, No. 3. Fall, 2006

An Australian study shows that vitamin E can actually raise blood pressure in hypertensive patients with Type 2 Diabetes. Though it is not clear whether this occurs in people without hypertension, the data suggest that diabetics need to be very careful with this antioxidant vitamin.

Rethinking Hyperlipidemia and Natural Treatment Options for Women at Risk

By Tori Hudson, ND | Contributing Writer - Vol. 7, No. 3. Fall, 2006

A recent metanalysis is challenging the notion that soy protein and soy isoflavones can improve women's cholesterol profiles. But the study did not account for the fact that some women convert soy isoflavones into equol, a powerful phytoestrogen, while others do not. In a separate study, German researchers found that policosanol, a sugar cane derived substance, had no meaningful effect on lipid profiles or cardiovascular risk.

In the Thick of It: Blood Viscosity Emerges as Key Heart Risk Factor

By August West | Contributing Writer - Vol. 8, No. 1. Spring, 2007

Blood viscosity, the actual thickness of a person's blood, is emerging as an important risk factor for heart disease: thicker blood means higher risk. New technology will soon enable doctors to measure viscosity routinely. Best of all, an enzyme derived from the Japanese soy food called natto, can effectively lower blood viscosity with minimal risk of side effects.

Does C-reactive Protein Have a Place in the CVD Risk Pantheon?

By Michael Traub, ND - Vol. 8, No. 1. Spring, 2007

One of the hottest debates in cardiology for the past few years centers on the question of whether C-reactive protein is a meaningful risk indicator for heart disease. It clearly correlates with a tendency toward inflammation, but is it truly causative? Dr. Traub contends that even if there's no direct causal relationship, an elevated CRP is telling you that something's wrong---something that warrants attention.

"Bad Cholesterol": Good Marketing, But Is It Good Medicine?

By Cleaves M. Bennett, MD | Contributing Writer - Vol. 8, No. 3. Fall, 2007

The cholesterol model of heart disease, which labels LDL as “bad” and HDL as “good,” has certainly helped drug companies sell a lot of statin medications. But has it really reduced the impact of obesity, heart disease and diabetes in this country? “Not really,” says Dr. Cleaves Bennett, one of the nation’s leading experts on hypertension, kidney disease and preventive medicine.

D, C and CVD: New Studies Correlate Deficiencies With Cardiovascular Risk

By August West | Contributing Writer - Vol. 9, No. 1. Spring, 2008

Two new studies provide fresh data showing that deficiencies in vitamin D and vitamin C are strongly associated with increased risk of myocardial infarction and stroke. The big-and still unanswered question---is whether supplementing with these vitamins will reduce that risk.

Digital Pulse Wave Analysis Offers Non-Invasive Early Heart Risk Assessment

By August West | Contributing Writer - Vol. 10, No. 2. Summer, 2009

Central Aortic Systolic Pressure (CASP) is one of the most powerful early predictors of cardiovascular risk. New digital pulse wave analysis technology is putting this valuable test in the hands of preventive primary care doctors.